13F HOLDINGS REPORT
Foresite Capital Management IV, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001104659-26-015407
Total Value
$229.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Pharvaris N.V. | PHVS | 4,778,581 | $132.6M | 57.73% |
| 2 | CYTOKINETICS INC | CYTK | 458,295 | $29.1M | 12.68% |
| 3 | Lyell Immunopharma, Inc. | LYEL | 800,399 | $24.6M | 10.72% |
| 4 | Maze Therapeutics, Inc. | MAZE | 522,657 | $21.7M | 9.43% |
| 5 | Relay Therapeutics, Inc. | RLAY | 1,000,000 | $8.5M | 3.68% |
| 6 | Xenon Pharmaceuticals Inc. | XENE | 160,000 | $7.2M | 3.12% |
| 7 | Alector, Inc. | ALEC | 3,887,200 | $6.1M | 2.64% |